Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening and early cancer detection.

C R Smart1

  • 1Early Detection Branch, National Cancer Institute, Bethesda, MD 20892-4200.

Seminars in Oncology
|August 1, 1990
PubMed
Summary
This summary is machine-generated.

The National Cancer Institute (NCI) funds research for mass cancer screening, with ongoing studies for prostate, lung, and colorectal cancers. Early cancer detection guidelines are provided to reduce cancer mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostate cancer facts and fiction.

Journal of surgical oncology·1998
Same author

The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program.

Cancer·1997
Same author

Limitations of the randomized trial for the early detection of cancer: a clinical perspective.

Cancer·1997
Same author

Twenty-year follow-up of the breast cancers diagnosed during the Breast Cancer Detection Demonstration Project.

CA: a cancer journal for clinicians·1997
Same author

Twenty-year follow-up of minimal breast cancer from the Breast Cancer Detection Demonstration Project.

Surgical oncology clinics of North America·1997
Same author

Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials.

Journal of the National Cancer Institute. Monographs·1997
Same journal

A systematic scoping review of cancer-related anemia treatment: Comparative trial outcomes, current guidelines, and future perspectives.

Seminars in oncology·2026
Same journal

Steroid-induced tumor lysis syndrome in solid tumors: A case report and review of the literature.

Seminars in oncology·2026
Same journal

PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation.

Seminars in oncology·2026
Same journal

Angiogenesis and the corresponding antiangiogenic therapy in gastroenteropancreatic neuroendocrine neoplasms.

Seminars in oncology·2026
Same journal

Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers.

Seminars in oncology·2026
Same journal

Physics-informed machine learning for tumor microenvironment-responsive nanomedicine: Recent updates.

Seminars in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Public Health
  • Cancer Screening Research

Background:

  • The National Cancer Institute (NCI) is a key funder of research establishing the benefits of mass cancer screening.
  • Large-scale trials for prostate, lung, and colorectal cancer screening are planned, requiring significant time and resources.
  • Screening trials are typically feasible only in high-incidence areas.

Purpose of the Study:

  • To inform physicians and oncologists about the benefits of early cancer detection.
  • To provide guidance on implementing cancer screening strategies.
  • To highlight the potential of early detection in reducing cancer mortality.

Main Methods:

  • The NCI is planning large-scale trials for prostate, lung, and colorectal cancer.
  • The NCI suggests Working Guidelines for the Early Detection of Cancer in seven key sites.

Related Experiment Videos

  • Evidence of benefit from mass cancer screening is being established through ongoing research.

    • Main Results:

    • Direct and/or indirect evidence suggests benefits for early cancer detection in seven specific sites.
    • The potential for decreasing cancer mortality through early detection is substantial.
    • The effectiveness of early detection relies on its application by the public and healthcare providers.

    Conclusions:

    • Early cancer detection holds significant promise for reducing cancer mortality.
    • Physicians and oncologists play a crucial role in applying early detection benefits to patients.
    • Adherence to screening guidelines is essential for realizing the benefits of early cancer detection.